Pharmaceuticals · Pharmaceuticals: Generic · NSE: ZIMLAB · data 2026-10-30

Zim Laboratories Ltd.

₹136.29-0.18% on 30 OctHealth: Weak 3.1/10

Feb 2026Low ₹60.26 · High ₹152.63+90.1%

In plain words

Price: 14.7% below its 52-week high of ₹159.81.

Delivery: 46.0% of traded shares were kept for delivery over the last 10 sessions, against 52.8% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹136.29

Market cap

₹733 cr

P/E

165.2

P/B

—

ROE

2.1%

ROCE

1.7%

Debt / equity

0.43

Dividend yield

0.00%

1-year return

72.5%

52-week high

₹159.81

52-week low

₹59.31

Operating margin

1.9%

Growth

Revenue (last 12 months)	₹397 cr
Net profit (last 12 months)	₹4 cr
Sales growth, 3 years (yearly)	-2.2%
Profit growth, 3 years (yearly)	-37.9%

Smart-money activity

8/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 3/30: Delivery 37.9% over the last 20 sessions vs 52.1% in the 40 before (0.73x); shares delivered per day 1.06x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Zim Laboratories Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.43.

What is Zim Laboratories Ltd.'s P/E ratio?

About 165.2, based on the last 12 months' earnings and a price of ₹136.29 (data 2026-10-30).

What is the 52-week high and low of Zim Laboratories Ltd.?

The 52-week high is ₹159.81 and the 52-week low is ₹59.31.

Similar companies

Anuh Pharma Limited (ANUHPHR) · Kilitch Drugs (India) Limited (KILITCH) · Hexagon Nutrition Limited (HEXAGON) · Valiant Laboratories Ltd. (VALIANTLAB) · Amanta Healthcare Limited (AMANTA)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ZIMLAB in NSE Scanner →